Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01647815
Other study ID # LOCAL/2012/PJ-02
Secondary ID 2012-A00624-39
Status Completed
Phase N/A
First received July 17, 2012
Last updated March 25, 2015
Start date August 2012
Est. completion date August 2012

Study information

Verified date March 2015
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santéFrance: Committee for the Protection of Personnes
Study type Interventional

Clinical Trial Summary

The main objective of this study is the demonstration of an increase of over 50% of the surface visible on ultrasound (mm2) of the axillary vein and subclavian vein in arm abduction (90 °) and external rotation (90 °) with respect to the surface of the subclavian vein along the arm body.


Description:

The secondary objective of this study is to investigate the anatomical relationships of these veins with the subclavian artery, the brachial plexus and the pleura, and assess the depth of the vein to the skin. Specifically, the following will be assessed:

- the depth of the vein (mm)

- the length of the minor axis (mm)

- the length of the major axis (mm)

- artery-vein distance (mm)

- vein-pleural distance (mm)

- the distance of the brachial plexus (mm)


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- The volunteer must have given his/her informed and signed consent

- The volunteer must be insured or beneficiary of a health insurance plan

- The volunteer is 18 to 50 years old

Exclusion Criteria:

- The volunteer is participating in another study

- The volunteer is in an exclusion period determined by a previous study

- The volunteer is under judicial protection, under tutorship or curatorship

- The volunteer refuses to sign the consent

- It is impossible to correctly inform the volunteer

- The volunteer is pregnant, parturient, or breastfeeding

- The volunteer has a contraindication for the exams in this study

- Volunteer with a history of trauma or surgery in the axilla or the shoulder girdle

- Volunteer with a known history of venous thrombosis in the axillary and / or subclavian veins

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Procedure:
Ultrasound measures
Ultrasound will be used to measure the surfaces of the axillary and subclavian veins with the arms in different positions. Our goal is to compare the vein surface area available among different vein-position combinations. Our goal does not include testing specific devices.

Locations

Country Name City State
France CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary vein surface (mm^2), subclavian vein with arm along side the body baseline (transversal); Day 0 No
Primary vein surface (mm^2), subclavian vein with arm in abduction and external rotation baseline (transversal); Day 0 No
Primary vein surface (mm^2), axillary vein with arm along side the body baseline (transversal); Day 0 No
Secondary Vein depth (mm), subclavian vein with arms along side the body baseline (transversal); Day 0 No
Secondary Length of minor axis (mm), subclavian vein with arms along side the body baseline (transversal); Day 0 No
Secondary Length of major axis (mm), subclavian vein with arms along side the body baseline (transversal); Day 0 No
Secondary Artery-vein distance is displayed in the section plane? yes/no Ultrasound of subclavian vein with arm along side the body. baseline (transversal); Day 0 No
Secondary Artery-vein distance (mm) Ultrasound of subclavian vein with arm along side the body.
Artery-vein distance is displayed in the section plane? = yes
baseline (transversal); Day 0 No
Secondary The vein-pleura distance is displayed in the section plane? yes/no Ultrasound of subclavian vein with arm along side the body. baseline (transversal); Day 0 No
Secondary Vein-pleura distance (mm) Ultrasound of subclavian vein with arm along side the body.
The vein-pleura distance is displayed in the section plane? = yes
baseline (transversal); Day 0 No
Secondary The distance to the brachial plexus is visualized in the sectional plane? yes/no Ultrasound of subclavian vein with arm along side the body. baseline (transversal); Day 0 No
Secondary Distance to brachial plexus (mm) Ultrasound of subclavian vein with arm along side the body.
The distance of the brachial plexus is visualized in the sectional plane? = yes
baseline (transversal); Day 0 No
Secondary Vein depth (mm), subclavian vein with arm in abduction and external rotation baseline (transversal); Day 0 No
Secondary Length of minor axis (mm), subclavian vein with arm in abduction and external rotation baseline (transversal); Day 0 No
Secondary Length of major axis (mm), subclavian vein with arm in abduction and external rotation baseline (transversal); Day 0 No
Secondary Vein depth (mm), axillary vein with arm along side the body baseline (transversal); Day 0 No
Secondary Length of minor axis (mm), axillary vein with arm along side the body baseline (transversal); Day 0 No
Secondary Length of major axis (mm), axillary vein with arm along side the body baseline (transversal); Day 0 No
Secondary Artery-vein distance is displayed in the section plane? yes/no Ultrasound of subclavian vein with arm in abduction and external rotation. baseline (transversal); Day 0 No
Secondary Artery-vein distance (mm) Ultrasound of subclavian vein with arm in abduction and external rotation.
Artery-vein distance is displayed in the section plane? = yes
baseline (transversal); Day 0 No
Secondary The vein-pleura distance is displayed in the section plane? yes/no Ultrasound of subclavian vein with arm in abduction and external rotation. baseline (transversal); Day 0 No
Secondary The distance to the brachial plexus is visualized in the sectional plane? yes/no Ultrasound of subclavian vein with arm in abduction and external rotation. baseline (transversal); Day 0 No
Secondary Vein-pleura distance (mm) Ultrasound of subclavian vein with arm in abduction and external rotation.
The vein-pleura distance is displayed in the section plane? = yes
baseline (transversal); Day 0 No
Secondary Distance to brachial plexus (mm) Ultrasound of subclavian vein with arm in abduction and external rotation.
The distance of the brachial plexus is visualized in the sectional plane? = yes
baseline (transversal); Day 0 No
Secondary Artery-vein distance is displayed in the section plane? yes/no Ultrasound of axillary vein with arm along side the body. baseline (transversal); Day 0 No
Secondary Artery-vein distance (mm) Ultrasound of axillary vein with arm along side the body.
Artery-vein distance is displayed in the section plane? = yes
baseline (transversal); Day 0 No
Secondary The vein-pleura distance is displayed in the section plane? yes/no Ultrasound of axillary vein with arm along side the body. baseline (transversal); Day 0 No
Secondary Vein-pleura distance (mm) Ultrasound of axillary vein with arm along side the body.
The vein-pleura distance is displayed in the section plane? = yes
baseline (transversal); Day 0 No
Secondary Distance to brachial plexus (mm) Ultrasound of axillary vein with arm along side the body.
The distance of the brachial plexus is visualized in the sectional plane? = yes
baseline (transversal); Day 0 No
Secondary The distance to the brachial plexus is visualized in the sectional plane? yes/no Ultrasound of axillary vein with arm along side the body. baseline (transversal); Day 0 No
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1